We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

68 hedge funds and large institutions have $79.9M invested in BioDelivery Sciences International, Inc. in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $263K | Put options by funds: $95K

30% more capital invested

Capital invested by funds: $61.6M → $79.9M (+$18.4M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

0% more funds holding

Funds holding: 6868 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

29% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 21

Holders
68
Holders Change
Holders Change %
0%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
15
Reduced
21
Closed
10
Calls
$263K
Puts
$95K
Net Calls
+$168K
Net Calls Change
+$46K
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
76
Balyasny Asset Management
Illinois
-$26K -11,381 Closed
Bank of America
77
Bank of America
North Carolina
-$2.12K -894 -86%

BDSI Hedge Fund Activity: Q2 2018 in Review

68 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2018, worth a combined $79.9M — up 30% from $61.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BDSI positions and 10 closed out — a net gain of 1 holder — while 15 added to existing stakes and 21 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $4.52M. The largest seller was Stonepine Capital Management, cutting an estimated $5.26M.

  • 68 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $79.9M of BioDelivery Sciences International, Inc. stock for Q2 2018, up 30% quarter-over-quarter.
  • 11 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2018 and 10 closed out, a net change of +1 holder.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2018 was Cortina Asset Management, an estimated $4.52M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2018 was Stonepine Capital Management, an estimated $5.26M sold.

Based on aggregated 13F filings for Q2 2018.